1 December 2022 - Takeda Pharmaceuticals Korea said Kynteles SC, an inflammatory bowel disease treatment, started to be covered by health insurance on Thursday.
Kynteles SC is subcutaneously injectable at home with the same efficacy as Kynteles intravenous injection.